Biolinq Inc

Biolinq Inc has raised $238.0M in total funding. The most recent round was Series C.

Biolinq Inc is headquartered in San Diego, CA.

People managing glucose need a way to see real-time, in-context glucose information (tied to activity and sleep) without relying on a needle-based sensor or checking a phone.

Biolinq Shine is a continuous intradermal glucose sensor with a color-changing LED light that shows real-time glucose range, paired with a mobile app that correlates glucose with meals, activity, and sleep.

It is described as the first fully autonomous, needle-free glucose sensor, is FDA cleared, and can convey in-range/out-of-range status via its LED light even without a phone present.

Founded in 2012 by two UC San Diego PhD alumni, Jared Tangney and Josh Windmiller, originally under the name Electrozyme.